PI3K/AKT/mTOR通路
蛋白激酶B
势垒函数
溃疡性结肠炎
医学
肠粘膜
信号转导
炎症性肠病
结肠炎
药理学
免疫学
癌症研究
生物
内科学
细胞生物学
疾病
作者
Xinhui Zhang,Fan Zhang,Yan Li,Na Fan,Ke Zhao,Anding Zhang,Jiefang Kang,Lin Yan,Xiaochang Xue,Xun Jiang
标识
DOI:10.1186/s12967-024-05168-w
摘要
Our study highlights that AS-IV exerts a protective effect on the integrality of the mucosal barrier in UC based on the PI3K/AKT pathway, and AS-IV may serve as a novel AKT inhibitor to provide a potential therapy for UC.
科研通智能强力驱动
Strongly Powered by AbleSci AI